| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | DNA replication | TICRR SDE2 ACTR8 RBBP7 DACH1 E4F1 JADE1 TTF1 ESCO1 BLM RMI1 BOD1L1 SLX4 | 1.65e-06 | 312 | 167 | 13 | GO:0006260 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | CARMIL2 PARD3B ARHGEF11 PLEKHG3 GPSM2 MARK2 PATJ PARD3 CORO7 MPP7 KIF2C | 8.27e-06 | 257 | 167 | 11 | GO:0007163 |
| GeneOntologyBiologicalProcess | chromatin remodeling | ACTR8 SETD1B ARID4B CENPN RBBP7 JADE1 RAD54L2 KMT2E ATAD2 TTF1 TRIP12 ZBTB1 TASOR2 RLF H2AP ATAD2B SPOCD1 KDM6A UTY | 9.39e-06 | 741 | 167 | 19 | GO:0006338 |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 1.44e-05 | 177 | 167 | 9 | GO:0030010 | |
| GeneOntologyBiologicalProcess | chromatin organization | ACTR8 SETD1B ARID4B CENPN RBBP7 JADE1 RAD54L2 KMT2E ATAD2 TTF1 TRIP12 ZBTB1 TASOR2 RLF ZZZ3 H2AP ATAD2B SPOCD1 KDM6A UTY | 3.96e-05 | 896 | 167 | 20 | GO:0006325 |
| GeneOntologyCellularComponent | nuclear speck | NRIP1 CACNB4 SDE2 SETD1B DACH1 JADE1 RAD54L2 KMT2E TRIP12 NCBP3 SART1 CDK13 TENM1 SRRM2 | 1.14e-05 | 431 | 169 | 14 | GO:0016607 |
| GeneOntologyCellularComponent | nuclear body | CASP8AP2 NRIP1 CACNB4 SDE2 SETD1B RAPH1 DACH1 E4F1 JADE1 RAD54L2 KMT2E TRIP12 ZBTB1 NCBP3 BLM SPTBN4 SART1 RMI1 CDK13 TENM1 SRRM2 | 1.34e-05 | 903 | 169 | 21 | GO:0016604 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 3.24e-05 | 75 | 169 | 6 | GO:0035097 | |
| GeneOntologyCellularComponent | methyltransferase complex | 2.47e-04 | 108 | 169 | 6 | GO:0034708 | |
| GeneOntologyCellularComponent | cell-cell junction | CARMIL2 PKP4 MPDZ EVPL PARD3B PANX2 PPL SPTBN4 LAT CTNND1 PATJ PARD3 MPP7 PDZD2 | 3.30e-04 | 591 | 169 | 14 | GO:0005911 |
| GeneOntologyCellularComponent | RecQ family helicase-topoisomerase III complex | 3.86e-04 | 4 | 169 | 2 | GO:0031422 | |
| GeneOntologyCellularComponent | cell cortex region | 4.74e-04 | 45 | 169 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | DNA helicase complex | 6.39e-04 | 5 | 169 | 2 | GO:0033202 | |
| GeneOntologyCellularComponent | subapical complex | 6.39e-04 | 5 | 169 | 2 | GO:0035003 | |
| GeneOntologyCellularComponent | bicellular tight junction | 6.94e-04 | 131 | 169 | 6 | GO:0005923 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 8.22e-04 | 90 | 169 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | presynapse | CACNB4 PSEN1 FZD3 ERC1 SYT6 ANO1 SYT9 OPRM1 BRAF SYNJ1 PTPRN2 SLC18A2 GNB5 CNTNAP4 CTNND1 USH2A KIF2C | 8.64e-04 | 886 | 169 | 17 | GO:0098793 |
| GeneOntologyCellularComponent | cell cortex | 9.05e-04 | 371 | 169 | 10 | GO:0005938 | |
| GeneOntologyCellularComponent | tight junction | 9.46e-04 | 139 | 169 | 6 | GO:0070160 | |
| GeneOntologyCellularComponent | anchoring junction | CARMIL2 PKP4 MPDZ EVPL PARD3B PANX2 PPL OPRM1 SPTBN4 LAT ARHGAP31 SVIL CTNND1 PATJ PARD3 ARHGAP21 MPP7 PDZD2 | 9.57e-04 | 976 | 169 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | glutamatergic synapse | DLGAP2 CACNB4 PSEN1 HTR4 FZD3 ERC1 SPTB SYT6 ANO1 MPDZ HNRNPD BRAF SYNJ1 MARK2 CTNND1 KIF2C | 9.93e-04 | 817 | 169 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | desmosome | 1.47e-03 | 28 | 169 | 3 | GO:0030057 | |
| GeneOntologyCellularComponent | apical junction complex | 1.82e-03 | 158 | 169 | 6 | GO:0043296 | |
| Domain | PDZ | MPDZ PARD3B ARHGEF11 TIAM2 MAST1 PATJ PARD3 ARHGAP21 MPP7 PDZD2 | 7.00e-07 | 141 | 171 | 10 | PF00595 |
| Domain | PDZ | MPDZ PARD3B ARHGEF11 TIAM2 MAST1 PATJ PARD3 ARHGAP21 MPP7 PDZD2 | 1.09e-06 | 148 | 171 | 10 | SM00228 |
| Domain | - | MPDZ PARD3B ARHGEF11 TIAM2 MAST1 PATJ PARD3 ARHGAP21 MPP7 PDZD2 | 1.23e-06 | 150 | 171 | 10 | 2.30.42.10 |
| Domain | PDZ | MPDZ PARD3B ARHGEF11 TIAM2 MAST1 PATJ PARD3 ARHGAP21 MPP7 PDZD2 | 1.31e-06 | 151 | 171 | 10 | PS50106 |
| Domain | PDZ | MPDZ PARD3B ARHGEF11 TIAM2 MAST1 PATJ PARD3 ARHGAP21 MPP7 PDZD2 | 1.39e-06 | 152 | 171 | 10 | IPR001478 |
| Domain | L27_2 | 8.33e-05 | 2 | 171 | 2 | PF09045 | |
| Domain | E3_ub_ligase_SMURF1 | 8.33e-05 | 2 | 171 | 2 | IPR024928 | |
| Domain | DUF3534 | 8.33e-05 | 2 | 171 | 2 | IPR021922 | |
| Domain | DUF3534 | 8.33e-05 | 2 | 171 | 2 | PF12053 | |
| Domain | L27_2 | 8.33e-05 | 2 | 171 | 2 | IPR015132 | |
| Domain | Spectrin_repeat | 1.35e-04 | 29 | 171 | 4 | IPR002017 | |
| Domain | SPEC | 2.00e-04 | 32 | 171 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.00e-04 | 32 | 171 | 4 | IPR018159 | |
| Domain | L27 | 2.02e-04 | 13 | 171 | 3 | SM00569 | |
| Domain | L27 | 2.02e-04 | 13 | 171 | 3 | PS51022 | |
| Domain | L27_dom | 2.02e-04 | 13 | 171 | 3 | IPR004172 | |
| Domain | Pecanex_C | 4.94e-04 | 4 | 171 | 2 | PF05041 | |
| Domain | Spectrin_bsu | 4.94e-04 | 4 | 171 | 2 | IPR016343 | |
| Domain | Pecanex | 4.94e-04 | 4 | 171 | 2 | IPR007735 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CARMIL2 RAPH1 RBBP7 BCAS3 ERC1 WWP2 MPDZ PARD3B TRIP12 TAB3 NUAK2 C2CD3 NKD2 BRAF SYNJ1 ATXN1 PLEKHG3 PRRC2C STARD9 SVIL BOD1L1 MARK2 CTNND1 PATJ PARD3 SRRM2 ARHGAP21 KIF2C VCPIP1 ZC3HAV1 | 4.98e-17 | 861 | 173 | 30 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NRIP1 TRPC4AP BCAS3 WWP1 WWP2 SPTB PARD3B TTF1 ESCO1 TASOR2 PCNX2 RLF SPTBN4 ZBTB46 ATXN1 PTPRN2 CDK13 PLEKHG3 TLE3 KNDC1 MAST1 BOD1L1 ANKRD24 CTNND1 PATJ PARD3 ARHGEF26 KDM6A ZC3HAV1 PDZD2 | 6.47e-11 | 1489 | 173 | 30 | 28611215 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CASP8AP2 NRIP1 SETD1B RBBP7 ERC1 ZGRF1 POLR2C RAD54L2 BLM RMI1 ZZZ3 SYNJ1 PRRC2C UTP4 CSTB PATJ SLX4 KIF2C VCPIP1 | 1.42e-10 | 588 | 173 | 19 | 38580884 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CASP8AP2 TICRR ACTR8 ERF ARID4B LEMD3 RBBP7 POLR2C E2F6 E4F1 WDR76 TTF1 TRIP12 ESCO1 HNRNPD BLM SART1 RMI1 ZZZ3 CDK13 UTP4 ASXL2 SRRM2 KDM6A KIF2C VCPIP1 ZC3HAV1 | 3.07e-10 | 1294 | 173 | 27 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ARID4B RAPH1 BUD13 ATAD2 TRIP12 HNRNPD PPL BLM SART1 BRAF CDK13 TLE3 SVIL MARK2 PARD3 SRRM2 MN1 KDM6A VCPIP1 ZC3HAV1 | 2.18e-09 | 774 | 173 | 20 | 15302935 |
| Pubmed | PKP4 MPDZ HNRNPD DHX30 NCBP3 SART1 SVIL MARK2 CTNND1 PATJ ARHGAP21 ZC3HAV1 | 1.48e-08 | 274 | 173 | 12 | 34244482 | |
| Pubmed | DLGAP2 CACNB4 ERC1 PKP4 MPDZ ARHGEF11 ZBTB1 ITIH4 SPTBN4 SART1 CNTNAP5 SYNJ1 PTPRN2 PRRC2C SPHKAP SVIL CTNND1 PARD3 ARHGEF26 ARHGAP21 KIF2C | 1.63e-08 | 963 | 173 | 21 | 28671696 | |
| Pubmed | RAPH1 RBBP7 ERC1 DACH1 MPDZ TAB3 ZZZ3 SYNJ1 PRRC2C BOD1L1 CTNND1 PATJ PARD3 KDM6A VCPIP1 ZC3HAV1 | 1.85e-08 | 549 | 173 | 16 | 38280479 | |
| Pubmed | SETD1B ERC1 DHX30 PRRC2C STARD9 TLE3 SPHKAP MAST1 BOD1L1 ASXL2 SRRM2 ARHGAP21 VCPIP1 PDZD2 | 1.93e-08 | 407 | 173 | 14 | 12693553 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | RAPH1 ERC1 PKP4 EVPL PPL SYNJ1 SVIL CRYBG1 MARK2 CTNND1 PATJ PARD3 ARHGAP21 MPP7 VCPIP1 ZC3HAV1 | 2.75e-08 | 565 | 173 | 16 | 25468996 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | CARMIL2 LEMD3 WWP1 PKP4 ATAD2 BRAF ARHGAP31 GPSM2 MARK2 CTNND1 PATJ PARD3 ARHGEF26 ARHGAP21 MPP7 | 1.91e-07 | 569 | 173 | 15 | 30639242 |
| Pubmed | DLGAP2 CACNB4 CARMIL2 RBBP7 BCAS3 ERC1 PKP4 SPTB ARHGEF11 HNRNPD DHX30 NUAK2 SPTBN4 TTC7B SYNJ1 PRRC2C SVIL GNB5 KNDC1 MAST1 MARK2 CTNND1 CORO7 ARHGAP21 | 2.00e-07 | 1431 | 173 | 24 | 37142655 | |
| Pubmed | CASP8AP2 NRIP1 RAPH1 ERC1 ZGRF1 E2F6 ZBTB1 RLF ZZZ3 SYNJ1 TLE3 ARHGAP21 VCPIP1 | 2.01e-07 | 418 | 173 | 13 | 34709266 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | LINC00322 RAPH1 ERC1 BUD13 PKD1L2 TRIP12 RLF SPTBN4 SART1 CDK13 PRRC2C SRRM2 | 2.97e-07 | 361 | 173 | 12 | 26167880 |
| Pubmed | LEMD3 WWP1 WWP2 E4F1 TTF1 TRIP12 PPL DHX30 RLF CDK13 SDF4 ASXL2 LTBP3 KDM6A VCPIP1 | 3.09e-07 | 591 | 173 | 15 | 15231748 | |
| Pubmed | TICRR CENPN WWP1 MARCHF7 JADE1 ANKRD6 TRIP12 TIAM2 BRAF SYNJ1 CRYBG1 SDF4 BOD1L1 ASXL2 PATJ PARD3 ARHGAP21 SLX4 LRRC71 KIF2C | 5.26e-07 | 1084 | 173 | 20 | 11544199 | |
| Pubmed | UBE2J1 ERC1 MPDZ HNRNPD PRRC2C BOD1L1 MARK2 CTNND1 PATJ PARD3 ARHGEF26 ARHGAP21 MPP7 KIF2C VCPIP1 ZC3HAV1 | 5.75e-07 | 708 | 173 | 16 | 39231216 | |
| Pubmed | 8.27e-07 | 35 | 173 | 5 | 33864728 | ||
| Pubmed | LEMD3 TAB3 NKD2 SVIL TENM1 CTNND1 PARD3 ARHGAP21 VCPIP1 ZC3HAV1 | 8.89e-07 | 263 | 173 | 10 | 34702444 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ERC1 PKP4 POLR2C BUD13 EVPL TRIP12 HNRNPD PPL TASOR2 DHX30 SART1 PLEKHG3 PRRC2C UTP4 SVIL CRYBG1 MARK2 CTNND1 PATJ KIF2C ZC3HAV1 | 1.32e-06 | 1257 | 173 | 21 | 36526897 |
| Pubmed | A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells. | 1.34e-06 | 17 | 173 | 4 | 16678097 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KIF27 ARID4B BCAS3 DACH1 E2F6 E4F1 TTF1 FAAP100 TRIP12 BLM SART1 PRRC2C TLE3 A2ML1 ASXL2 CTNND1 KIF2C | 1.50e-06 | 857 | 173 | 17 | 25609649 |
| Pubmed | Interaction network of human early embryonic transcription factors. | ERF ARID4B E2F6 RAD54L2 RLF ZZZ3 ATXN1 TLE3 ASXL2 KDM6A SLX4 | 1.66e-06 | 351 | 173 | 11 | 38297188 |
| Pubmed | NRIP1 ACTR8 ERC1 SPTB POLR2C RAD54L2 ANKRD6 TRIP12 LRP1B DHX30 SPTBN4 TTC7B SYNJ1 MAST1 GPSM2 ANKRD24 LTBP3 KDM6A ARHGAP21 SLX4 VCPIP1 | 1.86e-06 | 1285 | 173 | 21 | 35914814 | |
| Pubmed | Two forms of human Inscuteable-related protein that links Par3 to the Pins homologues LGN and AGS3. | 2.39e-06 | 6 | 173 | 3 | 16458856 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SDE2 RBBP7 DACH1 RAD54L2 BLM SART1 RMI1 ZZZ3 TLE3 CORO7 SLX4 ZC3HAV1 | 2.58e-06 | 444 | 173 | 12 | 34795231 |
| Pubmed | FLG ACTR8 ERF ARID4B DACH1 E2F6 RAD54L2 ZBTB1 TAB3 DHX30 BLM RLF ZZZ3 ATXN1 PRRC2C TLE3 SVIL ASXL2 SRRM2 KDM6A SLX4 ZC3HAV1 | 2.74e-06 | 1429 | 173 | 22 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1B BCAS3 WWP1 NLRX1 JADE1 ARHGEF11 FAAP100 TIAM2 TBC1D17 DHX30 PCNX2 C2CD3 ARAP3 SYNJ1 CDK13 PCNX1 SDF4 LTBP3 ARHGAP21 | 2.89e-06 | 1105 | 173 | 19 | 35748872 |
| Pubmed | 4.03e-06 | 22 | 173 | 4 | 23658188 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 4.03e-06 | 22 | 173 | 4 | 26886794 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 4.21e-06 | 313 | 173 | 10 | 38270169 | |
| Pubmed | RAPH1 LEMD3 ERC1 PKP4 POLR2C HID1 TAB3 BLM C2CD3 TTC7B PTPRN2 TLE3 SVIL SDF4 CTNND1 SRRM2 KDM6A MPP7 | 5.50e-06 | 1049 | 173 | 18 | 27880917 | |
| Pubmed | LEMD3 RBBP7 PKP4 POLR2C MPDZ BUD13 E4F1 ARHGEF11 ATAD2 TTF1 DHX30 BLM CDK13 PLEKHG3 UTP4 CRYBG1 MARK2 PATJ PARD3 MPP7 KIF2C ZC3HAV1 | 5.74e-06 | 1497 | 173 | 22 | 31527615 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ARID4B LEMD3 RBBP7 DACH1 BUD13 TRIP12 HNRNPD TASOR2 NCBP3 BLM SART1 ZZZ3 PRRC2C ATAD2B BOD1L1 SRRM2 SLX4 | 6.23e-06 | 954 | 173 | 17 | 36373674 |
| Pubmed | 6.65e-06 | 8 | 173 | 3 | 20888340 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | TICRR ARID4B BUD13 TTF1 TRIP12 HNRNPD DHX30 NCBP3 BLM SART1 CDK13 PRRC2C MARK2 KIF2C ZC3HAV1 | 6.67e-06 | 759 | 173 | 15 | 35915203 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TRPC4AP LEMD3 RBBP7 MPDZ EVPL FAAP100 PPL ARAP3 PTPRN2 CIBAR1 MARK2 CORO7 SRRM2 MPP7 KIF2C VCPIP1 ZC3HAV1 | 8.16e-06 | 974 | 173 | 17 | 28675297 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | NRIP1 RBBP7 WWP1 POLR2C DACH1 E2F6 E4F1 JADE1 ANKRD6 ZBTB1 ANKRD55 HNRNPD ANKRD53 ZZZ3 NKD2 INSM2 | 8.84e-06 | 877 | 173 | 16 | 20211142 |
| Pubmed | LEMD3 PKP4 PARD3B TTC7B CIBAR1 MARK2 CTNND1 PARD3 ARHGAP21 MPP7 ZC3HAV1 | 9.36e-06 | 421 | 173 | 11 | 36976175 | |
| Pubmed | 9.49e-06 | 27 | 173 | 4 | 23001562 | ||
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 1.26e-05 | 102 | 173 | 6 | 15778465 | |
| Pubmed | Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. | 1.41e-05 | 10 | 173 | 3 | 22421440 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1B PKP4 POLR2C ATAD2 TRIP12 HNRNPD DHX30 BLM RLF SART1 ARAP3 PLEKHG3 UTP4 A2ML1 CTNND1 PARD3 CORO7 SRRM2 KIF2C ZC3HAV1 | 1.45e-05 | 1353 | 173 | 20 | 29467282 |
| Pubmed | Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. | 1.71e-05 | 161 | 173 | 7 | 36398662 | |
| Pubmed | RAD54L2 FAAP100 ZBTB1 HNRNPD BLM RMI1 ZZZ3 SDF4 BOD1L1 SLX4 KIF2C | 1.85e-05 | 453 | 173 | 11 | 29656893 | |
| Pubmed | 2.35e-05 | 233 | 173 | 8 | 37704626 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 12810704 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 35642329 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 11062259 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 29562502 | ||
| Pubmed | An H-YDb epitope is encoded by a novel mouse Y chromosome gene. | 2.46e-05 | 2 | 173 | 2 | 8944031 | |
| Pubmed | PATJ regulates directional migration of mammalian epithelial cells. | 2.46e-05 | 2 | 173 | 2 | 17235357 | |
| Pubmed | Phenotypic spectrum of BLM- and RMI1-related Bloom syndrome. | 2.46e-05 | 2 | 173 | 2 | 35218564 | |
| Pubmed | BLM and SLX4 play opposing roles in recombination-dependent replication at human telomeres. | 2.46e-05 | 2 | 173 | 2 | 28877996 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 17264675 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 15033990 | ||
| Pubmed | DEXH-Box protein DHX30 is required for optimal function of the zinc-finger antiviral protein. | 2.46e-05 | 2 | 173 | 2 | 21204022 | |
| Pubmed | PATJ and MPDZ are required for trophectoderm lineage specification in early mouse embryos. | 2.46e-05 | 2 | 173 | 2 | 37318097 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 36932261 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 18820940 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 33565714 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 18434530 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 27533081 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 15758204 | ||
| Pubmed | Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation. | 2.46e-05 | 2 | 173 | 2 | 31097364 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 36604386 | ||
| Pubmed | Interaction of periplakin and envoplakin with intermediate filaments. | 2.46e-05 | 2 | 173 | 2 | 12432088 | |
| Pubmed | Par3 controls epithelial spindle orientation by aPKC-mediated phosphorylation of apical Pins. | 2.46e-05 | 2 | 173 | 2 | 20933426 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 31965758 | ||
| Pubmed | PAR-6-PAR-3 mediates Cdc42-induced Rac activation through the Rac GEFs STEF/Tiam1. | 2.46e-05 | 2 | 173 | 2 | 15723051 | |
| Pubmed | ERF PKP4 MPDZ RAD54L2 LMBRD2 TBC1D17 ARAP3 CDK13 PRRC2C MARK2 PATJ ARHGAP21 ZC3HAV1 | 2.47e-05 | 650 | 173 | 13 | 38777146 | |
| Pubmed | RBBP7 POLR2C EVPL ATAD2 FAAP100 ZBTB1 HNRNPD PPL BLM SART1 RMI1 SVIL SRRM2 | 2.55e-05 | 652 | 173 | 13 | 31180492 | |
| Pubmed | 2.57e-05 | 12 | 173 | 3 | 12973351 | ||
| Pubmed | RBBP7 ATAD2 TTF1 TRIP12 TASOR2 DHX30 BLM SART1 PRRC2C UTP4 ATAD2B SRRM2 ZC3HAV1 | 2.59e-05 | 653 | 173 | 13 | 22586326 | |
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 3.08e-05 | 36 | 173 | 4 | 26053890 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.50e-05 | 180 | 173 | 7 | 35198878 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | ACTR8 SETD1B RBBP7 E2F6 TRIP12 RLF ZZZ3 LYPD3 BOD1L1 ASXL2 KDM6A | 4.13e-05 | 495 | 173 | 11 | 27705803 |
| Pubmed | 4.23e-05 | 14 | 173 | 3 | 20347429 | ||
| Pubmed | K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling. | 4.23e-05 | 14 | 173 | 3 | 31015455 | |
| Pubmed | ACTR8 ERF ARID4B RBBP7 ERC1 WWP1 PKP4 POLR2C BUD13 ITIH4 SART1 ZZZ3 ATXN1 CIBAR1 SDF4 PARD3 SRRM2 | 4.56e-05 | 1116 | 173 | 17 | 31753913 | |
| Pubmed | 4.65e-05 | 332 | 173 | 9 | 25693804 | ||
| Pubmed | ERF ERC1 WWP2 TRIP12 BLM BRAF CDK13 TLE3 MARK2 SRRM2 ZC3HAV1 | 4.78e-05 | 503 | 173 | 11 | 16964243 | |
| Pubmed | 4.97e-05 | 130 | 173 | 6 | 12421765 | ||
| Pubmed | BNC2 ERF E2F6 JADE1 ATAD2 SART1 ZBTB46 ATXN1 TLE3 JRK ZSCAN5C KDM6A UTY ZC3HAV1 | 5.72e-05 | 808 | 173 | 14 | 20412781 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SDE2 ARID4B RBBP7 WDR76 ATAD2 TRIP12 NCBP3 BLM RLF UTP4 ATAD2B BOD1L1 | 5.80e-05 | 608 | 173 | 12 | 36089195 |
| Pubmed | RAPH1 RBBP7 PKP4 MPDZ ARHGEF11 TIAM2 ARAP3 ARHGAP31 PLEKHG3 UTP4 CSTB CTNND1 PATJ ARHGEF26 ARHGAP21 | 5.84e-05 | 916 | 173 | 15 | 32203420 | |
| Pubmed | UBE2J1 DLGAP2 CACNB4 BCAS3 ERC1 PANX2 LRP1B TAB3 SYNJ1 PRRC2C SPHKAP GNB5 TENM1 KNDC1 CSTB CTNND1 VCPIP1 | 5.86e-05 | 1139 | 173 | 17 | 36417873 | |
| Pubmed | TICRR EPSTI1 BCAS3 PKP4 SPTB SYT6 DDIAS ZBTB46 PTPRN2 ATAD2B PATJ ACKR1 MPP7 PDZD2 | 6.18e-05 | 814 | 173 | 14 | 23251661 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | CASP8AP2 ARID4B RBBP7 WWP1 WWP2 PKP4 POLR2C DACH1 DHX30 CIBAR1 CSTB CTNND1 PATJ SRRM2 ARHGAP21 | 6.28e-05 | 922 | 173 | 15 | 27609421 |
| Pubmed | DLGAP2 SYT6 SART1 PTPRN2 STARD9 MAST1 MARK2 CTNND1 PARD3 ARHGAP21 | 6.38e-05 | 430 | 173 | 10 | 32581705 | |
| Pubmed | 6.46e-05 | 16 | 173 | 3 | 20347428 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TRPC4AP LEMD3 BUD13 FAAP100 ESCO1 HNRNPD PPL TASOR2 DHX30 BLM SART1 RMI1 SVIL LYPD3 ASXL2 MARK2 SLX4 | 6.95e-05 | 1155 | 173 | 17 | 20360068 |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 11294830 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 31863478 | ||
| Pubmed | Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice. | 7.36e-05 | 3 | 173 | 2 | 23474291 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 34929254 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 11086001 | ||
| Pubmed | Direct interaction of Alzheimer's disease-related presenilin 1 with armadillo protein p0071. | 7.36e-05 | 3 | 173 | 2 | 10092585 | |
| Pubmed | Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility. | 7.36e-05 | 3 | 173 | 2 | 24843010 | |
| Pubmed | Colorectal cancer and polymorphisms in DNA repair genes WRN, RMI1 and BLM. | 7.36e-05 | 3 | 173 | 2 | 19945966 | |
| Interaction | NUP43 interactions | CASP8AP2 LRP12 SETD1B ERF ARID4B BUD13 E2F6 RAD54L2 ATAD2 TTF1 TRIP12 TASOR2 NCBP3 BLM RLF ZZZ3 PRRC2C ATAD2B CSTB BOD1L1 ASXL2 SRRM2 SLX4 PDZD2 | 6.55e-10 | 625 | 171 | 24 | int:NUP43 |
| Interaction | YWHAH interactions | NRIP1 TICRR CARMIL2 BCAS3 ERC1 MPDZ PARD3B TRIP12 ANKRD55 TAB3 NUAK2 C2CD3 NKD2 BRAF SYNJ1 ATXN1 PLEKHG3 PRRC2C STARD9 SVIL MAST1 BOD1L1 MARK2 CTNND1 PATJ PARD3 SRRM2 ARHGAP21 KIF2C VCPIP1 ZC3HAV1 | 3.41e-09 | 1102 | 171 | 31 | int:YWHAH |
| Interaction | HCFC1 interactions | ACTR8 SETD1B RBBP7 WWP2 KMT2E ZZZ3 ATXN1 PRRC2C CIBAR1 BOD1L1 ASXL2 KDM6A SLX4 | 1.38e-06 | 293 | 171 | 13 | int:HCFC1 |
| Interaction | YWHAG interactions | TICRR CARMIL2 RAPH1 BCAS3 ERC1 MPDZ PARD3B TRIP12 ANKRD55 TAB3 C2CD3 NKD2 BRAF SYNJ1 ATXN1 PLEKHG3 PRRC2C STARD9 SVIL BOD1L1 MARK2 CTNND1 PATJ PARD3 SRRM2 ARHGAP21 KIF2C ZC3HAV1 | 2.18e-06 | 1248 | 171 | 28 | int:YWHAG |
| Interaction | WWTR1 interactions | RAPH1 RBBP7 ERC1 MPDZ TTF1 TAB3 ZZZ3 SYNJ1 PRRC2C CTNND1 PATJ PARD3 KDM6A VCPIP1 ZC3HAV1 | 3.31e-06 | 422 | 171 | 15 | int:WWTR1 |
| Interaction | EN1 interactions | 4.48e-06 | 110 | 171 | 8 | int:EN1 | |
| Interaction | INSC interactions | 5.89e-06 | 31 | 171 | 5 | int:INSC | |
| Interaction | HDAC1 interactions | CASP8AP2 NRIP1 ACTR8 ARID4B RAPH1 RBBP7 BCAS3 ERC1 ZGRF1 WWP2 DACH1 E2F6 E4F1 KMT2E WDR76 ZBTB1 ESCO1 HNRNPD RLF ZZZ3 SYNJ1 ATXN1 TLE3 ARHGAP21 VCPIP1 | 7.43e-06 | 1108 | 171 | 25 | int:HDAC1 |
| Interaction | H2BC21 interactions | TICRR ARID4B RBBP7 WWP2 POLR2C JADE1 WDR76 ATAD2 TTF1 TRIP12 ESCO1 BLM RLF C2CD3 ZZZ3 SVIL TENM1 CRYBG1 SRRM2 | 7.57e-06 | 696 | 171 | 19 | int:H2BC21 |
| Interaction | FLNA interactions | TRPC4AP PSEN1 RBBP7 ZGRF1 WWP2 WDR76 ZBTB1 ANKRD55 HNRNPD OPRM1 PLEKHG3 TLE3 SVIL ASXL2 PATJ SRRM2 ARHGAP21 SLX4 | 1.06e-05 | 648 | 171 | 18 | int:FLNA |
| Interaction | C1orf35 interactions | FLG TRPC4AP DACH1 EVPL PPL NUAK2 SART1 ATXN1 A2ML1 MAST1 SRRM2 SLX4 | 1.16e-05 | 304 | 171 | 12 | int:C1orf35 |
| Interaction | PAXIP1 interactions | SETD1B CARMIL2 ERF RBBP7 PKP4 BLM SVIL MAST1 BOD1L1 SRRM2 KDM6A SLX4 KIF2C | 1.25e-05 | 359 | 171 | 13 | int:PAXIP1 |
| Interaction | GLDC interactions | PKP4 MPDZ HNRNPD DHX30 NCBP3 SART1 SVIL MARK2 CTNND1 PATJ ARHGAP21 ZC3HAV1 | 2.00e-05 | 321 | 171 | 12 | int:GLDC |
| Interaction | STK11 interactions | FLG BCAS3 PKP4 DACH1 EVPL PPL NUAK2 BRAF A2ML1 LYPD3 MARK2 PARD3 | 2.32e-05 | 326 | 171 | 12 | int:STK11 |
| Interaction | HNF4A interactions | NRIP1 ARID4B DACH1 E2F6 RAD54L2 BLM ZZZ3 ATXN1 ASXL2 KDM6A SLX4 | 2.40e-05 | 275 | 171 | 11 | int:HNF4A |
| Interaction | C2CD4B interactions | 3.45e-05 | 44 | 171 | 5 | int:C2CD4B | |
| Interaction | ELF4 interactions | 5.68e-05 | 115 | 171 | 7 | int:ELF4 | |
| Interaction | FEV interactions | 6.10e-05 | 203 | 171 | 9 | int:FEV | |
| Interaction | SPTBN4 interactions | 6.45e-05 | 50 | 171 | 5 | int:SPTBN4 | |
| Interaction | ECT2 interactions | SPTB TRIP12 HNRNPD DHX30 BLM SPTBN4 SART1 PLEKHG3 UTP4 SVIL CSTB LYPD3 CNTNAP4 GPSM2 BOD1L1 PARD3 SRRM2 ARHGAP21 ZC3HAV1 PDZD2 | 6.65e-05 | 887 | 171 | 20 | int:ECT2 |
| Interaction | PAX6 interactions | ACTR8 ARID4B DACH1 E2F6 RLF SYNJ1 ATXN1 TLE3 ASXL2 PATJ KDM6A GPANK1 | 7.12e-05 | 366 | 171 | 12 | int:PAX6 |
| Interaction | YWHAQ interactions | NRIP1 TICRR CARMIL2 ERC1 WWP1 WWP2 SPTB ANO1 PARD3B WDR76 TRIP12 ANKRD55 TAB3 NKD2 BRAF ATXN1 PLEKHG3 STARD9 SVIL MARK2 CTNND1 PARD3 ARHGAP21 | 7.45e-05 | 1118 | 171 | 23 | int:YWHAQ |
| Interaction | H3C1 interactions | SETD1B ARID4B LEMD3 RBBP7 BCAS3 JADE1 WDR76 ATAD2 TRIP12 ESCO1 BLM RLF ATXN1 CDK13 PRRC2C TLE3 CSTB KDM6A KIF2C PDZD2 | 8.24e-05 | 901 | 171 | 20 | int:H3C1 |
| Interaction | SFN interactions | RBBP7 PARD3B JADE1 TRIP12 HNRNPD TAB3 NUAK2 BRAF ATXN1 PLEKHG3 PRRC2C SVIL MARK2 PARD3 SRRM2 ARHGAP21 VCPIP1 | 8.68e-05 | 692 | 171 | 17 | int:SFN |
| Interaction | CDH1 interactions | PSEN1 RAPH1 ERC1 PKP4 EVPL PPL NKD2 SYNJ1 SVIL CRYBG1 MARK2 CTNND1 PATJ PARD3 ARHGAP21 MPP7 VCPIP1 ZC3HAV1 | 9.69e-05 | 768 | 171 | 18 | int:CDH1 |
| Interaction | PRPF40A interactions | NRIP1 RBBP7 SYT6 NCBP3 RLF SART1 ATXN1 CDK13 ASXL2 LTBP3 MARK2 SRRM2 PDZD2 | 1.16e-04 | 446 | 171 | 13 | int:PRPF40A |
| Interaction | ERG interactions | 1.25e-04 | 223 | 171 | 9 | int:ERG | |
| Interaction | YWHAZ interactions | TICRR CARMIL2 RAPH1 ERC1 WWP2 PARD3B WDR76 TRIP12 ANKRD55 HNRNPD TAB3 NUAK2 NKD2 BRAF ATXN1 PLEKHG3 STARD9 SVIL MAST1 SDF4 ASXL2 MARK2 CTNND1 PARD3 ARHGAP21 | 1.31e-04 | 1319 | 171 | 25 | int:YWHAZ |
| Interaction | TEAD1 interactions | 1.32e-04 | 176 | 171 | 8 | int:TEAD1 | |
| Interaction | P2RX6 interactions | 1.43e-04 | 59 | 171 | 5 | int:P2RX6 | |
| Interaction | KDM1A interactions | CASP8AP2 NRIP1 RAPH1 RBBP7 ERC1 ZGRF1 E2F6 WDR76 ZBTB1 ESCO1 RLF ZZZ3 GABPB2 SYNJ1 ATXN1 PLEKHG3 TLE3 JRK ARHGAP21 VCPIP1 | 1.48e-04 | 941 | 171 | 20 | int:KDM1A |
| Interaction | AMOTL1 interactions | 1.59e-04 | 95 | 171 | 6 | int:AMOTL1 | |
| Interaction | EPB41L4A interactions | 1.95e-04 | 140 | 171 | 7 | int:EPB41L4A | |
| GeneFamily | PDZ domain containing | MPDZ PARD3B ARHGEF11 TIAM2 MAST1 PATJ PARD3 ARHGAP21 MPP7 PDZD2 | 1.10e-07 | 152 | 126 | 10 | 1220 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.87e-05 | 206 | 126 | 8 | 682 | |
| GeneFamily | C2 and WW domain containing | 2.86e-04 | 4 | 126 | 2 | 838 | |
| GeneFamily | EF-hand domain containing|Spectrins | 9.89e-04 | 7 | 126 | 2 | 1113 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.16e-03 | 66 | 126 | 4 | 722 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.31e-03 | 8 | 126 | 2 | 939 | |
| GeneFamily | Ankyrin repeat domain containing | 1.55e-03 | 242 | 126 | 7 | 403 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 1.68e-03 | 9 | 126 | 2 | 1223 | |
| GeneFamily | WD repeat domain containing | 2.42e-03 | 262 | 126 | 7 | 362 | |
| GeneFamily | Low density lipoprotein receptors | 3.57e-03 | 13 | 126 | 2 | 634 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 3.57e-03 | 13 | 126 | 2 | 170 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.03e-03 | 46 | 126 | 3 | 622 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN | KIF27 PSEN1 DACH1 LMBRD2 NCBP3 DDIAS SYNJ1 ATXN1 CIBAR1 KIF2C | 5.75e-07 | 191 | 172 | 10 | M9973 |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_DN | 6.52e-06 | 197 | 172 | 9 | M3173 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP | 7.37e-06 | 200 | 172 | 9 | M4604 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN | 7.37e-06 | 200 | 172 | 9 | M3747 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.01e-05 | 208 | 172 | 9 | M39233 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN | UBE2J1 NRIP1 SDE2 MARCHF7 JADE1 KMT2E ATAD2 ZBTB1 NUAK2 RLF BRAF PRRC2C TLE3 SVIL LYPD3 PCNX1 VCPIP1 ZC3HAV1 | 1.20e-05 | 844 | 172 | 18 | M41129 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CASP8AP2 TICRR CENPN EPSTI1 RBBP7 ZGRF1 WDR76 ATAD2 BLM DDIAS GPSM2 KIF2C | 1.50e-05 | 402 | 172 | 12 | MM454 |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | BNC2 TICRR CENPN SPTB PANX2 WDR76 ATAD2 BLM DDIAS ARHGAP31 TLE3 GPSM2 MN1 KIF2C | 3.61e-05 | 588 | 172 | 14 | M38992 |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 4.63e-05 | 195 | 172 | 8 | M13736 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_TH1_UP | 4.63e-05 | 195 | 172 | 8 | M5422 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP | 5.34e-05 | 199 | 172 | 8 | M7959 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 5.53e-05 | 200 | 172 | 8 | M6662 | |
| Coexpression | GSE24210_TCONV_VS_TREG_DN | 5.53e-05 | 200 | 172 | 8 | M7844 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE | LRP12 NLRX1 SPTB LRRC32 E2F6 IGSF10 TTC7B LAT SLC18A2 GNB5 PARD3 UTY ARHGAP21 SLX4 MPP7 | 5.69e-05 | 694 | 172 | 15 | M45731 |
| Coexpression | FISCHER_DREAM_TARGETS | CASP8AP2 TICRR CENPN ZGRF1 PKP4 JADE1 WDR76 ATAD2 TTF1 HNRNPD BLM DDIAS RMI1 GABPB2 UTP4 CRYBG1 GPSM2 KIF2C | 7.28e-05 | 969 | 172 | 18 | M149 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | NRIP1 BNC2 ABI3BP PKP4 PCDHB13 ANO1 KMT2E ESCO1 PCNX2 RLF GABPB2 SYNJ1 SLC18A2 PRRC2C CIBAR1 ASXL2 KDM6A VCPIP1 ZC3HAV1 | 1.60e-05 | 778 | 170 | 19 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NRIP1 BNC2 PKP4 PCDHB13 ANO1 PARD3B KMT2E ESCO1 NCBP3 RLF ATXN1 ARHGAP31 PRRC2C STARD9 CIBAR1 TLE3 KDM6A UTY VCPIP1 | 1.98e-05 | 790 | 170 | 19 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | UBE2J1 CASP8AP2 BNC2 TICRR ARID4B ERC1 MARCHF7 ANKRD6 ATAD2 IL18R1 ZBTB1 TBC1D17 DHX30 BLM IGSF10 DDIAS TTC7B NKD2 SLC18A2 ATAD2B GPSM2 BOD1L1 ASXL2 KDM6A KIF2C | 2.20e-05 | 1252 | 170 | 25 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | NRIP1 PKP4 PCDHB13 ANO1 PARD3B GABPB2 PRRC2C STARD9 LTBP3 MPP7 | 3.38e-05 | 249 | 170 | 10 | gudmap_developingGonad_P2_epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | LRP12 SETD1B HTR4 DACH1 ANKRD6 HNRNPD TIAM2 TASOR2 NKD2 TENM1 LYPD3 CNTNAP4 ASXL2 | 4.30e-05 | 428 | 170 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | BNC2 ABI3BP PKP4 PCDHB13 ANO1 WDR76 ESCO1 PCNX2 RLF ZP1 RNF167 SYNJ1 SLC18A2 PRRC2C CIBAR1 PARD3 KDM6A ZC3HAV1 | 4.79e-05 | 770 | 170 | 18 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | LRP12 SETD1B ARID4B HTR4 ITFG2 PCDHB13 DACH1 ANKRD6 HNRNPD TIAM2 TASOR2 BLM NKD2 STARD9 TENM1 LYPD3 CNTNAP4 ASXL2 KDM6A | 5.34e-05 | 850 | 170 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | NRIP1 BNC2 ABI3BP PKP4 PCDHB13 ANO1 PARD3B KMT2E ESCO1 RLF GABPB2 ATXN1 PRRC2C STARD9 CIBAR1 LTBP3 KDM6A MPP7 | 7.45e-05 | 797 | 170 | 18 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | NRIP1 BNC2 ABI3BP PKP4 PCDHB13 ANO1 PARD3B KMT2E ESCO1 RLF ATXN1 ARHGAP31 PRRC2C STARD9 CIBAR1 KDM6A UTY MPP7 | 7.69e-05 | 799 | 170 | 18 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.77e-05 | 275 | 170 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NRIP1 BNC2 PKP4 PCDHB13 ANO1 PARD3B KMT2E ESCO1 NCBP3 RLF GABPB2 ARHGAP31 PRRC2C STARD9 CIBAR1 TLE3 KDM6A UTY | 7.94e-05 | 801 | 170 | 18 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | TICRR CENPN EPSTI1 HID1 WDR76 ATAD2 IL18R1 LAT ATXN1 CRYBG1 GPSM2 KIF2C | 1.00e-04 | 402 | 170 | 12 | GSM605898_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CASP8AP2 WWP1 DACH1 JADE1 WDR76 ATAD2 ZBTB1 ESCO1 RLF SLC18A2 PRRC2C TLE3 ACKR1 KIF2C | 1.01e-04 | 532 | 170 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | TICRR CENPN ZGRF1 WDR76 ATAD2 IL18R1 BLM DDIAS LAT ATXN1 GPSM2 KIF2C | 1.21e-04 | 410 | 170 | 12 | GSM538387_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | NRIP1 BNC2 PKP4 PCDHB13 ANO1 KMT2E NCBP3 RLF GABPB2 PRRC2C STARD9 CIBAR1 | 1.29e-04 | 413 | 170 | 12 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.30e-04 | 97 | 170 | 6 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 1.74e-04 | 65 | 170 | 5 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | UBE2J1 TICRR ARID4B PKP4 ZBTB1 TBC1D17 DHX30 TTC7B SLC18A2 ATAD2B BOD1L1 ASXL2 | 1.96e-04 | 432 | 170 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.19e-04 | 151 | 170 | 7 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.87e-04 | 323 | 170 | 10 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.98e-04 | 210 | 170 | 8 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | NRIP1 BNC2 FZD3 PKP4 PCDHB13 KMT2E ESCO1 NCBP3 RLF GABPB2 SLC18A2 PRRC2C CIBAR1 TLE3 SPHKAP KDM6A VCPIP1 | 3.03e-04 | 815 | 170 | 17 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | UBE2J1 CASP8AP2 TICRR ARID4B FZD3 ERC1 DACH1 SYT9 ANKRD6 TTF1 IL18R1 FAM83C DHX30 BLM SLC18A2 ATAD2B GPSM2 BOD1L1 IGLON5 KIF2C | 3.29e-04 | 1060 | 170 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_200 | 3.62e-04 | 76 | 170 | 5 | gudmap_developingGonad_e16.5_epididymis_200_k4 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | TICRR CENPN ZGRF1 WDR76 ATAD2 BLM DDIAS LAT GPSM2 MPP7 KIF2C | 3.77e-04 | 398 | 170 | 11 | GSM399397_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 3.89e-04 | 166 | 170 | 7 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | NRIP1 BNC2 PKP4 PCDHB13 ANO1 PARD3B KMT2E RLF PRRC2C STARD9 CIBAR1 | 4.28e-04 | 404 | 170 | 11 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | NRIP1 BNC2 PKP4 PCDHB13 ANO1 KMT2E NCBP3 RLF PRRC2C CIBAR1 KDM6A | 4.46e-04 | 406 | 170 | 11 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.88e-04 | 284 | 170 | 9 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.47e-04 | 230 | 170 | 8 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | UBE2J1 ARID4B ZGRF1 PKP4 MARCHF7 E2F6 ZBTB1 SART1 ZZZ3 ATXN1 ATAD2B BOD1L1 ASXL2 MPP7 | 5.57e-04 | 629 | 170 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ARID4B RAPH1 ZGRF1 PKP4 MARCHF7 E2F6 ZBTB1 SART1 DDIAS ZZZ3 TTC7B ATAD2B ASXL2 | 6.36e-04 | 564 | 170 | 13 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#4_top-relative-expression-ranked_500 | 6.40e-04 | 86 | 170 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k4_500 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-09 | 192 | 173 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.97e-08 | 175 | 173 | 9 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | CASP8AP2 ARID4B RBBP7 MARCHF7 JADE1 KMT2E NCBP3 PRRC2C SRRM2 | 4.79e-08 | 185 | 173 | 9 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.35e-08 | 200 | 173 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 9.35e-08 | 200 | 173 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.73e-07 | 155 | 173 | 8 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-07 | 169 | 173 | 8 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.76e-07 | 177 | 173 | 8 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-07 | 184 | 173 | 8 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.39e-07 | 184 | 173 | 8 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.46e-07 | 191 | 173 | 8 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.46e-07 | 191 | 173 | 8 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.07e-06 | 197 | 173 | 8 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-06 | 198 | 173 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.15e-06 | 199 | 173 | 8 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.13e-06 | 151 | 173 | 7 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-06 | 165 | 173 | 7 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-06 | 165 | 173 | 7 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-06 | 165 | 173 | 7 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.15e-06 | 167 | 173 | 7 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.15e-06 | 167 | 173 | 7 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.85e-06 | 171 | 173 | 7 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.85e-06 | 171 | 173 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 174 | 173 | 7 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 174 | 173 | 7 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 7.30e-06 | 182 | 173 | 7 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-06 | 183 | 173 | 7 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-06 | 185 | 173 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.42e-06 | 186 | 173 | 7 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.42e-06 | 186 | 173 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-06 | 187 | 173 | 7 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.02e-06 | 188 | 173 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.02e-06 | 188 | 173 | 7 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.34e-06 | 189 | 173 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.67e-06 | 190 | 173 | 7 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.67e-06 | 190 | 173 | 7 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.67e-06 | 190 | 173 | 7 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.67e-06 | 190 | 173 | 7 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-05 | 191 | 173 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.00e-05 | 191 | 173 | 7 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.03e-05 | 192 | 173 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.03e-05 | 192 | 173 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.03e-05 | 192 | 173 | 7 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.07e-05 | 193 | 173 | 7 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.07e-05 | 193 | 173 | 7 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.11e-05 | 194 | 173 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.11e-05 | 194 | 173 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.14e-05 | 195 | 173 | 7 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.14e-05 | 195 | 173 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.14e-05 | 195 | 173 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 195 | 173 | 7 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 195 | 173 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.14e-05 | 195 | 173 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 196 | 173 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 196 | 173 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.18e-05 | 196 | 173 | 7 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.18e-05 | 196 | 173 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.22e-05 | 197 | 173 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.22e-05 | 197 | 173 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 198 | 173 | 7 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 1.26e-05 | 198 | 173 | 7 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.26e-05 | 198 | 173 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 1.26e-05 | 198 | 173 | 7 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-05 | 198 | 173 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.31e-05 | 199 | 173 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.31e-05 | 199 | 173 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.31e-05 | 199 | 173 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 199 | 173 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 173 | 7 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 173 | 7 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.35e-05 | 200 | 173 | 7 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.35e-05 | 200 | 173 | 7 | 3e3de496508efb2f95e5e8684f97687381e96493 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.35e-05 | 200 | 173 | 7 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 173 | 7 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.35e-05 | 200 | 173 | 7 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 200 | 173 | 7 | 0bba93f1271dac704dddcdea8cb0f84a7ac6f42a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 200 | 173 | 7 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 200 | 173 | 7 | c9479452ab8c51139522383f745f02171ebbd7e2 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 137 | 173 | 6 | e9b88ad86b75454a8292a94879c5b665adc42744 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.67e-05 | 138 | 173 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 145 | 173 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.58e-05 | 149 | 173 | 6 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.68e-05 | 150 | 173 | 6 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.34e-05 | 156 | 173 | 6 | 84f01419d8c116714e8c8c857c4d153a755b7867 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.34e-05 | 156 | 173 | 6 | 2285be9746d0d0f62a488b9c64fa67a834758dd7 | |
| ToppCell | Adult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor | 3.99e-05 | 161 | 173 | 6 | 44f5c0256b3ce264a6c7b62740f32dcd45ee052d | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.13e-05 | 162 | 173 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.27e-05 | 163 | 173 | 6 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | 356C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-05 | 164 | 173 | 6 | b3192c443f4848e6a8afdb89c155f9ec42a154b0 | |
| ToppCell | 356C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-05 | 164 | 173 | 6 | f7288ec4daf494dae770ea6c58bead27660ccae1 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.73e-05 | 166 | 173 | 6 | a697460dfe72e08fbf7d8e734a16b7dd2c6d86f9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 167 | 173 | 6 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 5.22e-05 | 169 | 173 | 6 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 5.40e-05 | 170 | 173 | 6 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | COVID-19_Mild-Neu_2|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 5.76e-05 | 172 | 173 | 6 | f5fd08b42c002d4693646b27e7b708eceb49524f | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.76e-05 | 172 | 173 | 6 | 980e8b9e1ceeb0dec9eb9ef95c139e5ffe99b6e4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-05 | 174 | 173 | 6 | 2947e5906b172d149412fa4e77476fce4ea695d2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.54e-05 | 176 | 173 | 6 | 116741fef5895ca85057d2d31eca9eba5764ab44 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-05 | 176 | 173 | 6 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.54e-05 | 176 | 173 | 6 | 5b707f58d164ee7a6a527dd5d053472ce9a631c1 | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; PC3; HT_HG-U133A | 2.78e-06 | 198 | 172 | 10 | 7399_DN | |
| Drug | Urosiol [128-13-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.78e-06 | 198 | 172 | 10 | 7243_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.97e-06 | 173 | 172 | 9 | 4565_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.65e-06 | 175 | 172 | 9 | 7387_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; HL60; HG-U133A | 1.68e-05 | 193 | 172 | 9 | 1982_DN | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.90e-05 | 196 | 172 | 9 | 7382_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; HL60; HG-U133A | 1.90e-05 | 196 | 172 | 9 | 1790_DN | |
| Drug | fludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A | 1.97e-05 | 197 | 172 | 9 | 282_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.97e-05 | 197 | 172 | 9 | 6930_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.06e-05 | 198 | 172 | 9 | 7366_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.23e-05 | 200 | 172 | 9 | 3442_DN | |
| Disease | Kabuki syndrome (implicated_via_orthology) | 9.40e-05 | 3 | 166 | 2 | DOID:0060473 (implicated_via_orthology) | |
| Disease | optic disc size measurement | 1.68e-04 | 205 | 166 | 7 | EFO_0004832 | |
| Disease | Epilepsy, Atonic | 1.87e-04 | 4 | 166 | 2 | C0086236 | |
| Disease | Epilepsy, Tonic | 1.87e-04 | 4 | 166 | 2 | C0086241 | |
| Disease | Generalized convulsive epilepsy | 1.87e-04 | 4 | 166 | 2 | C0311334 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.87e-04 | 4 | 166 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Symptomatic Generalized Epilepsy | 1.87e-04 | 4 | 166 | 2 | C0270854 | |
| Disease | Impulsive Petit Mal Epilepsy | 1.87e-04 | 4 | 166 | 2 | C4553298 | |
| Disease | Juvenile Myoclonic Epilepsy of Janz | 1.87e-04 | 4 | 166 | 2 | C4551857 | |
| Disease | Generalized Nonconvulsive Seizure Disorder | 1.87e-04 | 4 | 166 | 2 | C0017332 | |
| Disease | Myoclonic Epilepsy, Adolescent | 1.87e-04 | 4 | 166 | 2 | C4552768 | |
| Disease | intrahepatic cholangiocarcinoma (is_implicated_in) | 1.87e-04 | 4 | 166 | 2 | DOID:4928 (is_implicated_in) | |
| Disease | Myoclonic Epilepsy, Juvenile, 1 | 1.87e-04 | 4 | 166 | 2 | C4553087 | |
| Disease | Epilepsy, Akinetic | 1.87e-04 | 4 | 166 | 2 | C0347869 | |
| Disease | urate measurement, bone density | CASP8AP2 DLGAP2 ERC1 MARCHF7 PPL TIAM2 CNTNAP5 PTPRN2 A2ML1 USH2A MPP7 PDZD2 | 2.12e-04 | 619 | 166 | 12 | EFO_0003923, EFO_0004531 |
| Disease | early-onset Parkinson's disease (implicated_via_orthology) | 4.65e-04 | 6 | 166 | 2 | DOID:0060894 (implicated_via_orthology) | |
| Disease | Epilepsy, Generalized | 4.65e-04 | 6 | 166 | 2 | C0014548 | |
| Disease | HWESASXX measurement | 6.49e-04 | 7 | 166 | 2 | EFO_0021147 | |
| Disease | eosinophil count | NRIP1 BNC2 HTR1E CARMIL2 KIF27 HTR4 WWP2 LRRC32 ANO1 BUD13 LMBRD2 IL18R1 ITIH4 ATXN1 TLE3 PCNX1 LTBP3 CORO7 ZC3HAV1 | 7.40e-04 | 1488 | 166 | 19 | EFO_0004842 |
| Disease | t-tau measurement | 7.49e-04 | 126 | 166 | 5 | EFO_0004760 | |
| Disease | melanoma | 7.49e-04 | 126 | 166 | 5 | EFO_0000756 | |
| Disease | cup-to-disc ratio measurement | 7.72e-04 | 430 | 166 | 9 | EFO_0006939 | |
| Disease | pentachlorophenol measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022058 | |
| Disease | environmental exposure measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 8.18e-04 | 74 | 166 | 4 | EFO_0007886 | |
| Disease | Juvenile Myoclonic Epilepsy | 8.61e-04 | 8 | 166 | 2 | C0270853 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 8.61e-04 | 8 | 166 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | reticulocyte measurement | BNC2 PSEN1 SPTB ANKRD55 FAM83C ATXN1 ATAD2B MAST1 ASXL2 CTNND1 CORO7 SPOCD1 ARHGAP21 ZC3HAV1 PDZD2 | 9.32e-04 | 1053 | 166 | 15 | EFO_0010700 |
| Disease | body surface area | BNC2 TICRR E4F1 ANKRD6 TRIP12 TIAM2 OPRM1 LTBP3 PATJ PARD3 ARHGEF26 | 1.09e-03 | 643 | 166 | 11 | EFO_0022196 |
| Disease | leptin measurement | 1.15e-03 | 81 | 166 | 4 | EFO_0005000 | |
| Disease | influenza A (H1N1) | 1.50e-03 | 87 | 166 | 4 | EFO_1001488 | |
| Disease | obsolete_red blood cell distribution width | NRIP1 SETD1B CARMIL2 PSEN1 BCAS3 SPTB BUD13 LMBRD2 ANKRD6 MROH8 NKD2 PRRC2C ATAD2B MAST1 CRYBG1 ASXL2 ARHGAP21 | 1.60e-03 | 1347 | 166 | 17 | EFO_0005192 |
| Disease | virologic response measurement, response to abacavir | 1.71e-03 | 42 | 166 | 3 | EFO_0006905, EFO_0006906 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.73e-03 | 152 | 166 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.91e-03 | 93 | 166 | 4 | C1535926 | |
| Disease | birth weight | 1.97e-03 | 399 | 166 | 8 | EFO_0004344 | |
| Disease | stenosing tenosynovitis | 2.00e-03 | 12 | 166 | 2 | EFO_0010822 | |
| Disease | cancer | 2.00e-03 | 400 | 166 | 8 | MONDO_0004992 | |
| Disease | osteoarthritis, knee | 2.04e-03 | 158 | 166 | 5 | EFO_0004616 | |
| Disease | blood cobalt measurement | 2.58e-03 | 101 | 166 | 4 | EFO_0007577 | |
| Disease | Diuretic use measurement | 2.74e-03 | 169 | 166 | 5 | EFO_0009928 | |
| Disease | suntan | 2.77e-03 | 103 | 166 | 4 | EFO_0004279 | |
| Disease | Leukemia, Myelocytic, Acute | 3.03e-03 | 173 | 166 | 5 | C0023467 | |
| Disease | Malaria, susceptibility to | 3.58e-03 | 16 | 166 | 2 | cv:C1970028 | |
| Disease | – | 3.58e-03 | 16 | 166 | 2 | 611162 | |
| Disease | asthma, response to diisocyanate | 3.70e-03 | 261 | 166 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | leukemia | 3.70e-03 | 55 | 166 | 3 | C0023418 | |
| Disease | lymphocyte count | NRIP1 CARMIL2 KIF27 HTR4 RAPH1 BCAS3 WWP2 SPTB ARHGEF11 TRIP12 ZBTB1 ARHGAP31 CDK13 ATAD2B LTBP3 CORO7 ZC3HAV1 | 3.78e-03 | 1464 | 166 | 17 | EFO_0004587 |
| Disease | FEV/FEC ratio | BNC2 HTR4 BCAS3 ERC1 LRRC32 ANO1 IL18R1 TTC7B ARHGAP31 SVIL LTBP3 PARD3 ARHGEF26 MN1 MPP7 | 4.07e-03 | 1228 | 166 | 15 | EFO_0004713 |
| Disease | neurofilament light chain measurement | 4.10e-03 | 57 | 166 | 3 | EFO_0009178 | |
| Disease | Drug habituation | 4.12e-03 | 115 | 166 | 4 | C0013170 | |
| Disease | Drug abuse | 4.12e-03 | 115 | 166 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.12e-03 | 115 | 166 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 4.12e-03 | 115 | 166 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 4.12e-03 | 115 | 166 | 4 | C0013222 | |
| Disease | Drug Dependence | 4.12e-03 | 115 | 166 | 4 | C1510472 | |
| Disease | Substance Dependence | 4.12e-03 | 115 | 166 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 4.12e-03 | 115 | 166 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.12e-03 | 115 | 166 | 4 | C0029231 | |
| Disease | Substance abuse problem | 4.24e-03 | 116 | 166 | 4 | C0740858 | |
| Disease | response to efavirenz, virologic response measurement | 4.30e-03 | 58 | 166 | 3 | EFO_0006904, EFO_0006906 | |
| Disease | vital capacity | BNC2 HTR4 ERC1 WWP2 KMT2E TRIP12 TIAM2 RMI1 BRAF GABPB2 ATAD2B LTBP3 PATJ PARD3 PDZD2 | 4.32e-03 | 1236 | 166 | 15 | EFO_0004312 |
| Disease | blood nickel measurement | 4.79e-03 | 120 | 166 | 4 | EFO_0007583 | |
| Disease | cutaneous melanoma | 4.93e-03 | 121 | 166 | 4 | EFO_0000389 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 5.05e-03 | 19 | 166 | 2 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 5.05e-03 | 19 | 166 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 5.05e-03 | 19 | 166 | 2 | C1275081 | |
| Disease | Costello syndrome (disorder) | 5.05e-03 | 19 | 166 | 2 | C0587248 | |
| Disease | hemifacial microsomia | 5.05e-03 | 19 | 166 | 2 | MONDO_0015398 | |
| Disease | Malaria | 5.59e-03 | 20 | 166 | 2 | C0024530 | |
| Disease | Craniosynostosis | 5.59e-03 | 20 | 166 | 2 | C0010278 | |
| Disease | freckles | 5.59e-03 | 20 | 166 | 2 | EFO_0003963 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLQHAVPADDGTTRS | 496 | Q99569 | |
| QRARDTLPQSESHQE | 181 | Q15361 | |
| NRGRRSNHIPEEESS | 141 | Q4LE39 | |
| TPRRVSSDLQHATAQ | 526 | P50548 | |
| SDISSPRRVHNNSPD | 236 | Q9BRD0 | |
| DRSSSAPNVHINTIE | 361 | P15056 | |
| ARPANHSSTRERVAN | 36 | Q9BRK5 | |
| DDQQPVVLRRHSSSD | 1326 | Q8WWN8 | |
| IESNNRTRSPSLLAH | 286 | Q6ZN30 | |
| RGQSSDLPERLHSQE | 456 | Q9H981 | |
| RNNRADPASSDHTTR | 701 | Q6F5E8 | |
| ESSTPLHQAEDSQVR | 716 | A8K2U0 | |
| DLDHPGERQQISSTR | 271 | P28566 | |
| HRQPSDASETTGLVQ | 31 | O15085 | |
| HNGSDLTRVRNTNPE | 636 | Q9C0A0 | |
| PATAETQHIADQVRS | 11 | P04080 | |
| HRAELSPSTENSSQL | 6 | Q16570 | |
| AQRHLPESQSSSVRT | 681 | Q9P1A6 | |
| AQVPTASDSRTVHRS | 66 | Q96DR7 | |
| PSQRRHSTAAEESEH | 591 | Q3KP44 | |
| LAPVRSSRQDQIHSS | 536 | Q6PL18 | |
| RGQTASSHEQARSSP | 366 | P20930 | |
| SAQEQSRDGSRHPTS | 3566 | P20930 | |
| SSQSEPSEQLRRHQG | 76 | Q9Y4B4 | |
| SEALRQSVVPASEHR | 906 | Q8TF21 | |
| EVQQATHREASPSTL | 396 | P54253 | |
| TQQDSHAPLRDSRGS | 211 | Q7L2E3 | |
| DDVAIHSNSRRSPLV | 301 | Q9H6U6 | |
| TPGERSHSRVDSQSD | 326 | Q9UKL3 | |
| ARTESSSDRIPVHQN | 521 | Q9UI36 | |
| SNHSTENSPIERRSL | 441 | O00305 | |
| GRDDSPVSHRASQSL | 321 | Q14004 | |
| NSTREEVNERQSHPA | 1001 | Q76L83 | |
| SEQTGPHIRDTSQAL | 651 | Q9Y2G4 | |
| ASPEHVVVTRNRRSS | 796 | Q14624 | |
| ASTVPHSLRQARDNT | 136 | Q8IUD2 | |
| PLVTNQHRRTASAGT | 181 | Q70E73 | |
| HENRVSTLRVSPDGT | 366 | O14775 | |
| ASDVLARTHTAQDRP | 166 | Q92932 | |
| EVTNSNSAERRKPHS | 181 | Q9Y2U8 | |
| ESQRSRSFHPSVDAR | 346 | Q8N9V6 | |
| EERTIATQTGPHRAT | 6441 | Q8WXI7 | |
| RENNSPALHIRSVSA | 461 | Q9Y5F0 | |
| AVTTSRRNDNSILHP | 616 | Q8TEW8 | |
| NTRDHPSTANTVDRT | 371 | P35372 | |
| PSTANTVDRTNHQLE | 376 | P35372 | |
| GSQEHVELNPRSSSR | 61 | Q13478 | |
| DASNSIDHRIPNSQR | 466 | P81274 | |
| NNREPHSAESDVTRF | 91 | O75409 | |
| SQSTSREPERNHTHR | 631 | Q9Y561 | |
| SSITRHTVDQTRPGA | 2291 | Q9NZR2 | |
| VRESHGETRSPENRS | 196 | O95872 | |
| SHRTPSSRRDSDGAN | 91 | O43561 | |
| APVRSSRQDQIHSSI | 511 | Q9ULI0 | |
| TLPHNRTNLTSSAEE | 616 | O15550 | |
| QSSISPPAERQETHA | 166 | Q8NDZ0 | |
| PSRESVVHAGQRRTS | 51 | Q96J88 | |
| PRASQSTQAHENSRD | 201 | P57737 | |
| TQINREGSPDTNRIH | 381 | Q86VH2 | |
| DHSNTRLASQLDRNP | 1531 | Q96RV3 | |
| SHSVQSGLVRQSPAR | 2106 | Q96RV3 | |
| QSETPRHVSQDLEAS | 781 | A6NKB5 | |
| SRAHPQEAELVSSNV | 301 | O75564 | |
| THETLQRNRPDSGVE | 876 | O60437 | |
| SVAGNRQSEPRLASH | 2046 | O15018 | |
| RQSEPRLASHVAADT | 2051 | O15018 | |
| HSLGRSRDSQVPVTS | 2241 | O15018 | |
| GSPSRHSRAATQELA | 26 | Q92817 | |
| ADHSRLSVTPQRTTG | 456 | Q8IXT1 | |
| EERNTSNHRASSSPG | 426 | P47871 | |
| PHTTRARRSQESDGV | 401 | Q5T2T1 | |
| SSDVHSRLGVPRQDS | 516 | Q53F19 | |
| RAEPNSQLDSTHSGR | 1046 | Q8IZD2 | |
| TQERSRSPSSSRHGD | 326 | Q8N4P6 | |
| VRDLSPHRSNSVADS | 946 | P48552 | |
| RRVQHSDTPSGARSV | 81 | Q5XXA6 | |
| PSASATEAIQRHRRN | 71 | Q86UT6 | |
| NVLVQEERPHSLSSS | 136 | Q9H579 | |
| DHPGRSRSTSQDDRD | 91 | Q0VG06 | |
| RTADQHPQARDSSGA | 361 | Q96T92 | |
| RASHLQARSRSQEPD | 276 | Q969F2 | |
| QARSRSQEPDTHAVH | 281 | Q969F2 | |
| SRETPAARDVVLHQT | 231 | Q969R8 | |
| ALSPVQEHETGRRSS | 1411 | Q9Y2H9 | |
| TSQTPRQGVEHEASR | 276 | O95274 | |
| PHNETILASSGTDRR | 326 | Q16576 | |
| SSREQPGSLSQTRHS | 2436 | Q7Z442 | |
| RFSSQEEVSLSHVRP | 601 | Q14392 | |
| DHSALPNQSLTVRES | 1321 | Q8NFC6 | |
| VTHNGVNSAPDSRRV | 196 | A6NGN9 | |
| TNSHQTSVREVSEPR | 951 | Q6WRI0 | |
| HTASINDLERETQPS | 536 | P54132 | |
| CSSHSESEQLPRRND | 1576 | Q4AC94 | |
| REDSITVHIRSTNGP | 216 | O75461 | |
| RNPSDRHVISQAETE | 136 | A1XBS5 | |
| SSVHPRTLQTNEENS | 2021 | P17927 | |
| SLSLRRQESQPHSGS | 226 | Q6ZN03 | |
| REASGQPSLHRQLSD | 386 | Q9BQN1 | |
| TSEALVLNPRRHQDS | 31 | Q6P531 | |
| SESRPQSADQHSTHR | 236 | Q13639 | |
| QTFETHNSTTPLQER | 211 | Q96H22 | |
| PEASVQVHRIESSNA | 236 | Q9NS15 | |
| QVHRIESSNAESAAP | 241 | Q9NS15 | |
| PSEHQTILSSRDSRN | 206 | Q9H992 | |
| RGRNSATSADEQPHI | 36 | Q7KZI7 | |
| EQSRHSSIRDLSNNP | 631 | Q9NPG1 | |
| RINSTLTRAHQDPTS | 1296 | Q76NI1 | |
| QTSKSSDNRETPRNH | 561 | Q5FWF5 | |
| ETQVASEASAVPRTH | 421 | Q66K89 | |
| FENKRTNSSPRHTDI | 276 | Q9Y4K1 | |
| ATNVNCSSPERHTRS | 41 | P21781 | |
| SQRARVVNTDHGSPE | 266 | Q6IQ49 | |
| EQVHSIRGSSSANPV | 171 | Q99661 | |
| TPNERGDHNRTLDRS | 906 | O60716 | |
| DNLPRSTRETSEEGH | 891 | Q8WYK1 | |
| LAQSNHDATPTVRDS | 386 | Q96RD6 | |
| VDSNRSTPSNHDRIQ | 1141 | Q8TEW0 | |
| ARPATQSGRHSVSVE | 1186 | Q8TEW0 | |
| SEDRPQAVSSGHTRC | 116 | A6NNC1 | |
| SQASRPRINSALHVE | 736 | A6NNC1 | |
| GSDSHSLEPRRVTNQ | 211 | Q10571 | |
| TRHPAATAQLETAVR | 16 | Q9Y5Y5 | |
| NSSPRHSEAATAQRE | 81 | Q14103 | |
| VPLSNSHRATANTEE | 236 | Q8TAK5 | |
| HTRLQRQTTEPASST | 156 | Q5T7P8 | |
| RQVTEPTSSARHNSI | 156 | Q86SS6 | |
| DTTDRRQHTVTGLQP | 3636 | O75445 | |
| PTNESDVIRRRTAHA | 626 | Q969X6 | |
| SVSNRQPHGALTRVS | 486 | O14607 | |
| EQRSINSVTSLNSPH | 781 | O14607 | |
| QSQLSRSHRVPDSST | 811 | Q2M3C7 | |
| ERSESQTRDPEHQGR | 976 | Q7Z5M5 | |
| DHRSDTSSPEVRQSH | 1066 | Q9UQ35 | |
| SEENGLPHTSARTQL | 361 | Q8TEL6 | |
| HRSTPESRAAVQELS | 351 | P49768 | |
| ELASESVTQRRHQPA | 321 | O95425 | |
| AADEHRTGSTQSPRT | 661 | Q8N5C8 | |
| HARASAGRLTPESQS | 1211 | O43426 | |
| NREDSTRNRNIHTDP | 606 | Q68DH5 | |
| DRSIERFSHNPNTTN | 346 | Q9H9A7 | |
| SLHQDGSQERPVSLT | 6 | A1L390 | |
| PDFTVQSHRRSTVDS | 156 | Q8IV36 | |
| PTRGLIRATSDHNAS | 21 | Q9H6Y7 | |
| SRSVEDVRPHHTDAN | 876 | Q9Y520 | |
| ESQPSRKRSVSHGSN | 916 | Q9Y520 | |
| PSNSAVVSRQRHDDT | 56 | Q6P435 | |
| SDDTQHSPRNLILTS | 476 | Q9UKZ4 | |
| QPHASTRAGSERRSE | 1786 | Q9UPS6 | |
| HQTPRDGETSHRAQI | 636 | Q9P2P6 | |
| SQRHLDNTRAATSPG | 691 | Q6IE81 | |
| VNPTRRATLEDVASH | 286 | Q9H093 | |
| QTRHVTSRDLISNSP | 111 | P19387 | |
| AVTQHTPRASVGNRE | 1286 | Q8IY92 | |
| EQSSRRNEEGSHPSN | 21 | Q9NQW8 | |
| SVSPEQERRNSLLHG | 356 | Q9HA65 | |
| RDSSGTAVAPENRHQ | 166 | O00308 | |
| RHVLQTAVADSPRDT | 431 | Q7Z2Z1 | |
| SSGHRNDTARPQDIV | 556 | P60852 | |
| QRSESTHAIGSDPLR | 441 | Q8IVF5 | |
| FHSERRPSQSSQVSE | 1811 | O75970 | |
| PRIKESETRQHSSGQ | 1721 | Q13129 | |
| SQSRSPSEEREHRQS | 546 | B3KS81 | |
| RTPSKEGNHSQSRTS | 621 | B3KS81 | |
| SSHEEAITALRQTPQ | 1496 | Q8NI35 | |
| RGTDRSSDNSHQDRP | 436 | Q6ZMY3 | |
| SQRRLSTSPDVIQGH | 261 | Q9Y385 | |
| GHPDSEQISRRQSQV | 1691 | Q9H254 | |
| EEAQARSLATNHPAR | 251 | Q2M1Z3 | |
| ANSLVESGHPRSREV | 911 | P11277 | |
| DRHLRDQSTEQSPSD | 1121 | Q96JH7 | |
| SSTHGRERSQAEPSE | 76 | O43290 | |
| HRERESSANNSVSPS | 191 | Q04726 | |
| AEPSSTVNTPHNREA | 161 | Q9Y2K1 | |
| VSPGDRVRSHNSCES | 176 | O43296 | |
| NSRRSQPLISLTEHT | 481 | Q9H967 | |
| PISSSTSNLHVDREQ | 156 | Q86TV6 | |
| SPIHSSTVDGNDTER | 336 | Q86YA3 | |
| SLRHPVSTSENARTQ | 1091 | Q5VWN6 | |
| SSGHREISSPRIQDA | 451 | Q7Z2W4 | |
| ALHENGEPSARTTAR | 166 | Q9H0M0 | |
| DHNTRTTTFKDPRNG | 516 | Q9H0M0 | |
| RPSGADRNVSVDSTH | 676 | Q7Z7G0 | |
| QHSRDDSLDLSPQGR | 981 | Q14669 | |
| NATEIQTARPVHTAS | 56 | Q05940 | |
| SNRNNHTGPSHRTEE | 286 | Q5T5U3 | |
| RSIAHPEEISSNSQV | 31 | Q8IYH5 | |
| DDPRHVSSQRTSSVN | 156 | A6NGD5 | |
| HITQQVEDDSRASSP | 281 | Q86UZ6 |